Partial Inhibition of Epithelial-to-Mesenchymal Transition (EMT) Phenotypes by Placenta-Derived DBMSCs in Human Breast Cancer Cell Lines, In Vitro
Cells · 2024
DOI: 10.3390/cells13242131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Yasser Basmaeil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cells and Regenerative Medicine Unit, Blood and Cancer Research (BCR) Department, King Abdullah International Medical Research Center (KAIMRC), …. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Breast Neoplasms, Mesenchymal Stem Cells, Placenta. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdullah International Medical Research Center.
Abstract (Originalsprache)
Stem cell-based therapies hold significant potential for cancer treatment due to their unique properties, including migration toward tumor niche, secretion of bioactive molecules, and immunosuppression. Mesenchymal stem cells (MSCs) from adult tissues can inhibit tumor progression, angiogenesis, and apoptosis of cancer cells. We have previously reported the isolation and characterization of placenta-derived decidua basalis mesenchymal stem cells (DBMSCs), which demonstrated higher levels of pro-migratory and anti-apoptotic genes, indicating potential anti-cancer effects. In this study, we analyzed the anti-cancer effects of DBMSCs on human breast cancer cell lines MDA231 and MCF7, with MCF 10A used as control. We also investigated how these cancer cells lines affect the functional competence of DBMSCs. By co-culturing DBMSCs with cancer cells, we analyzed changes in functions of both cell types, as well as alterations in their genomic and proteomic profile. Our results showed that treatment with DBMSCs significantly reduced the functionality of MDA231 and MCF7 cells, while MCF 10A cells remained unaffected. DBMSC treatment decreased epithelial-to-mesenchymal transition (EMT)-related protein levels in MDA231 cells and modulated expression of other cancer-related genes in MDA231 and MCF7 cells. Although cancer cells reduced DBMSC proliferation, they increased their expression of anti-apoptotic genes. These findings suggest that DBMSCs can inhibit EMT-related proteins and reduce the invasive characteristics of MDA231 and MCF7 breast cancer cells, highlighting their potential as candidates for cell-based cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stem Cells and Regenerative Medicine Unit, Blood and Cancer Research (BCR) Department, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences (KSAU), Ministr…
- Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.
ORCID-Profile: Altaf A Kondkar, Tanvir Khatlani
Förderung
- King Abdullah International Medical Research Center
Zitieren
APA
Basmaeil, Y., Subayyil, A. A., Kulayb, H. B., Kondkar, A. A., Alrodayyan, M., & Khatlani, T. (2024). Partial Inhibition of Epithelial-to-Mesenchymal Transition (EMT) Phenotypes by Placenta-Derived DBMSCs in Human Breast Cancer Cell Lines, In Vitro. Cells. https://doi.org/10.3390/cells13242131
Vancouver
Basmaeil Y, Subayyil AA, Kulayb HB, Kondkar AA, Alrodayyan M, Khatlani T. Partial Inhibition of Epithelial-to-Mesenchymal Transition (EMT) Phenotypes by Placenta-Derived DBMSCs in Human Breast Cancer Cell Lines, In Vitro. Cells. 2024. doi:10.3390/cells13242131
BibTeX
@article{Basmaeil2024,
author = {Basmaeil, Yasser and Subayyil, Abdullah Al and Kulayb, Haya Bin and Kondkar, Altaf A and Alrodayyan, Maha and Khatlani, Tanvir},
title = {Partial Inhibition of Epithelial-to-Mesenchymal Transition (EMT) Phenotypes by Placenta-Derived DBMSCs in Human Breast Cancer Cell Lines, In Vitro},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13242131}
}
EUVIMED